The product overview describes this as a sandwich ELISA kit using qPCR as the detection method and positions it for semi-quantitative measurement of CCL9. That generally means it's excellent for robust relative comparisons (dose response, time-course, treatment ranking). If your project requires absolute concentration claims across multiple runs and matrices, we recommend validating key findings with a fully quantitative assay as part of your final reporting strategy.
We recommend including: (1) a no-template/blank control appropriate to your readout workflow, (2) a consistent positive control sample (aliquoted and frozen), and (3) a small dilution series of a pooled reference sample to confirm plate performance. With semi-quantitative assays, the pooled reference is especially helpful because it anchors your dataset to a stable point. Keeping extraction/handling consistent also matters, since variability often comes from upstream steps.
Yes-this is one of the most common use cases for semi-quantitative readouts. You can screen a broad treatment panel, identify high-responders, and then focus confirmatory work on a smaller subset. To make high-throughput screening reliable, we suggest running duplicates, using the same operator timing, and placing controls in multiple plate positions to monitor any edge effects. That way, you can trust rank-order conclusions across many samples.
For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.